Cencora, Inc. (ETR:ABG)

Market Cap	56.64B
Revenue (ttm)	273.87B
Net Income (ttm)	1.32B
Shares Out	n/a
EPS (ttm)	6.78
PE Ratio	42.76
Forward PE	19.25
Dividend	2.17 (0.75%)
Ex-Dividend Date	Nov 14, 2025

Volume	2
Average Volume	9
Open	289.95
Previous Close	288.20
Day's Range	289.95 - 290.45
52-Week Range	244.95 - 325.25
Beta	n/a
RSI	38.48
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ABG

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD